Denova Sciences Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Seed
- Investors
-
2
Denova Sciences General Information
Description
Provider of artificial skin model and tissue scaffolding services intended to validate, test, or develop dermatological products. The company's services use established in vitro skin models as a standardized testing platform to reduce variability in the analysis and interpretations of dermatological studies and material tissue engineering, enabling businesses to accurately test and analyze product effects on the skin.
Contact Information
Website
www.denovasciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
- NTU Innovation Center (NIC)
- 71 Nanyang Drive, Number 05-20
- Singapore, 638075
- Singapore
+65 9728 0000
Denova Sciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 09-May-2016 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | Completed | Startup |
Denova Sciences Executive Team (4)
Denova Sciences Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Daniel Tan | Denova Sciences | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Denova Sciences Signals
Denova Sciences Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Midana Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
NTUitive | Accelerator/Incubator | 000 0000 | 000000 0 |